glp-1 agonist benefits Receptor Agonists and Research to Treat Overeating and Substance Use Disorders GLP-1 Agonists: Dual Benefits for
Description
Anorexigenic lipopeptides ameliorate central insulin signaling and attenuate tau phosphorylation in hippocampi of mice with monosodium glutamate-induced obesity
Appetite drops
Institute of medicine measures of social and behavioral determinants of health: a feasibility study
Mean SEM
doi: 10.1016/j.mcna.2018.10.009 [DOI] [PubMed] [Google Scholar] 80
Commonly considered an undesirable off-target for molecular glue degrader programs, GSPT1 is emerging as a promising oncology target
